Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-E expressing autoreactive T cells are a subset of CD8+ T cells that recognize self-antigens presented by the non-classical MHC molecule HLA-E. These cells can contribute to both immune regulation and autoimmunity. HLA-E's limited polymorphism makes it an attractive target for immunotherapies, but careful consideration is needed to mitigate potential autoimmune side effects.
Redirects T cell cytotoxicity towards cells expressing specific HLA-E-peptide complexes; Modulation of NKG2A/CD94 mediated inhibition of T cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA-E expressing autoreactive T cell (N/A).